Vreni Schoenenberger, Ph.D

Vreni Schoenenberger, Ph.D has a diverse work experience. From 2012 to 2015, they served as an External Consultant for DuPont Sustainable Solutions. In 2015, they took on the role of Manager, Policy, Ethics and Compliance at IFPMA. From 2016 to 2020, they worked at Novartis in various roles, including Global Franchise Head, External Affairs and Partnerships (Commercial Development and Market Access), Executive Director, Global Head Of Public Affairs, Neuroscience, and Global Head of Strategy & Operations (Sandoz). In 2020, they became a Mentor at Creative Destruction Lab, where they mentored startups in medtech, digital health, omics, diagnostics, biomarker, and drug discovery platforms. In 2019, they joined the Board of the European Brain Council. In 2021, they became a Non-Executive Director at OKKO Health and a Venture Scout at Ada Ventures. Finally, in 2022, they became a Board Advisor for Neuronostics and a Venture Mentor for Imperial College London.

Vreni Schoenenberger, Ph.D. completed a Bachelor of Science (B.S.) degree in Bioethics at Vanderbilt University from 2001 to 2005. Vreni then spent 2003 to 2004 studying Bioethics/Medical Ethics at the University of Melbourne. Finally, they completed their Ph.D. in Modern Vreni'story & Policy with a subfocus in Global Health, Business at Yale University from 2006 to 2015.